New Weight-Loss Drugs Could Replace Ozempic with Fewer Side Effects

The weight-loss drug market is about to get a major upgrade. While millions currently use medications like Wegovy and Zepbound, researchers are racing to create even better alternatives.

## What Are GLP-1 Drugs?

GLP-1 drugs (medications that mimic a natural hormone controlling appetite) have revolutionized weight loss. Popular brands include: • Wegovy and Ozempic (made by Novo Nordisk) • Zepbound and Mounjaro (made by Eli Lilly)

These injectable medications help people lose 15-20% of their body weight but come with drawbacks like nausea, weekly injections, and high costs.

## The Next Generation

New experimental drugs aim to solve current problems: • Oral pills instead of injections • Fewer side effects like nausea and vomiting • Better weight loss results • Lower production costs

Several pharmaceutical companies (drug makers) are testing these new medications, with some showing promising results in early trials.

## Why This Matters

The weight-loss drug market is worth billions of dollars and growing rapidly. Companies that develop better alternatives could capture huge market share from current leaders Novo Nordisk and Eli Lilly. For patients, this means more choices and potentially more affordable treatments.

Investors are closely watching which companies will win this next phase of the weight-loss drug race.

This is an AI-generated summary. Read the original article at: https://www.marketwatch.com/story/tired-of-nausea-or-taking-a-glp-1-pill-every-day-these-experimental-drugs-could-be-better-than-zepbound-and-wegovy-587bf648?mod=mw_rss_topstories